Comparison 3. One systemic antifungal agent versus another agent or dose regimen.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Invasive fungal infection	2		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2 Death prior to hospital discharge	2		Risk Difference (M‐H, Random, 95% CI)	Subtotals only
3 Retinopathy of prematurity	2	297	Risk Ratio (M‐H, Fixed, 95% CI)	0.91 [0.60, 1.36]
4 Necrotising enterocolitis	1	216	Risk Ratio (M‐H, Fixed, 95% CI)	0.90 [0.28, 2.85]
5 Chronic lung disease	1	216	Risk Ratio (M‐H, Fixed, 95% CI)	0.92 [0.51, 1.65]